MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0015244
Synim Remedies Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5.13 Cr
▲ 14% YoY
Net profit · FY 2024
₹10.95 Lakh
Net margin 2.1%
EBITDA · FY 2024
₹16.72 Lakh
EBITDA margin 3.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
8
As per MCA filings
Active GSTINs
1
GST registered
About Synim Remedies Private Limited
Data last updated:
Synim Remedies Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2017PTC115968. Its GSTIN is 36AAYCS3486R1ZY (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sambu Murali Krishna and Juturi Guru Swamy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.13 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹10.95 Lakh (net margin 2.1%) and EBITDA of ₹16.72 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 24% over five years.
Synim Remedies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0015244). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synimremedies.com.
Company details
CIN U24239TG2017PTC115968
Registration Number 115968
Incorporation Date 17 March 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0015244
Recognitions & Rankings of Synim Remedies
Contact details
Synim Remedies Private Limited's registered office is in Hyderabad, Telangana. Its website is synimremedies.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address12 – 1 – 485/24/7/G1&G2 Dhana Lakshmi Nagar Rd No:1 Indra Prasta Colony Near Nagole L B Naga, R, Hyderabad, Telangana, India – 500068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synim Remedies Private Limited, buy the company report.
Comprehensive company report
Synim Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Synim Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Synim Remedies Private Limited, buy the company report.
Financials of Synim Remedies Private Limited
FY 2024 filings availableSynim Remedies Private Limited reported revenue of ₹5.13 Cr (up 14% YoY) for FY 2024.
Revenue · FY 2024
₹5.13 Cr ▲ 14%
Net profit · FY 2024
₹10.95 Lakh margin 2.1%
EBITDA · FY 2024
₹16.72 Lakh margin 3.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 32%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 43%
5 years · compounded
▲ 35%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 14% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synim Remedies Private Limited, buy the company report.
Board of directors of Synim Remedies Private Limited
Synim Remedies has 8 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sambu Murali Krishna | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Juturi Guru Swamy | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Siddam Meghana | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Juturi Shanthi Lakshmi | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Venkata Vishnu Swetha Darisi | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Latha Sambu | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Synim Remedies Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Roxford Healthcare Private Limited | ₹5.15 Cr (FY 2025) | -10.0% | Bathinda, Punjab, India | |||
| Biocrit Healthcare Private Limited | ₹5.14 Cr (FY 2025) | 108.0% | Pune, Maharashtra, India | |||
| Synim Remedies Private Limitedthis company | ₹5.13 Cr (FY 2024) | ₹10.95 Lakh | 2.1% | 14.0% | Hyderabad, Telangana, India | |
| Baxton Pharmacia Private Limited | ₹5.13 Cr (FY 2025) | 8.0% | Chandigarh, India |
To see the full peer comparison of Synim Remedies Private Limited, buy the company report.
Shareholding
The shareholding of Synim Remedies Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Synim Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synim Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synim Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synim Remedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAYCS3486R1ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Synim Remedies Private Limited, buy the company report.
Recent activity
Synim Remedies Private Limited has 9 board changes on record since 2017: 8 appointments and 1 cessation. The latest: Juturi Guru Swamy was appointed as Director on 20 Jul 2021.
AGM
Synim Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Synim Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Juturi Guru Swamy was appointed as Director.
Appointed
Juturi Shanthi Lakshmi was appointed as Director.
Appointed
Latha Sambu was appointed as Director.
Ceased
Nageswara Rao Nagasamudram ceased to be Director.
Appointed
Sambu Murali Krishna was appointed as Director.
Appointed
Siddam Meghana was appointed as Director.
Appointed
Venkata Vishnu Swetha Darisi was appointed as Director.
Appointed
Seshapani Kotra was appointed as Director.
Appointed
Siva Prasad Reddy Siddam was appointed as Director.
Incorporation
17 Mar 2017
Synim Remedies Private Limited was registered on 17 Mar 2017 with Roc Hyderabad & aged 9 years 7 months as per MCA records.
Frequently asked questions
Synim Remedies is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2017 (9+ years old) and is registered under CIN U24239TG2017PTC115968.
Synim Remedies has 8 current directors:
- Sambu Murali Krishna - Director
- Juturi Guru Swamy - Director
- Siddam Meghana - Director
- Juturi Shanthi Lakshmi - Director
- Venkata Vishnu Swetha Darisi - Director
- Latha Sambu - Director
- Siva Prasad Reddy Siddam - Director
- Seshapani Kotra - Director
The latest financial statements of Synim Remedies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Synim Remedies is 36AAYCS3486R1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Synim Remedies is U24239TG2017PTC115968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synim Remedies was incorporated on 17 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Synim Remedies by revenue are Roxford Healthcare Private Limited, Biocrit Healthcare Private Limited, Baxton Pharmacia Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Juturi Guru Swamy was appointed as Director on 20 Jul 2021. Juturi Shanthi Lakshmi was appointed as Director on 20 Jul 2021. Latha Sambu was appointed as Director on 20 Jul 2021. Synim Remedies has 9 board changes on record in total.
Yes, Synim Remedies is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0015244).
Synim Remedies can be reached through the website synimremedies.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Synim Remedies is at 12 – 1 – 485247G1&G2 Dhana Lakshmi Nagar Rd No:1 Indra Prasta Colony Near Nagole L B Naga, R, Hyderabad, Telangana, India – 500068.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages